308 related articles for article (PubMed ID: 22349930)
1. Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus.
Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y
Clin Rheumatol; 2012 Jun; 31(6):951-9. PubMed ID: 22349930
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.
Fassbinder T; Saunders U; Mickholz E; Jung E; Becker H; Schlüter B; Jacobi AM
Arthritis Res Ther; 2015 Apr; 17(1):92. PubMed ID: 25890338
[TBL] [Abstract][Full Text] [Related]
3. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and clustering analysis of peripheral blood lymphocyte subsets in children with systemic lupus erythematosus complicated with clinical infection.
Deng Y; Ou YY; Mo CJ; Huang L; Qin X
Clin Rheumatol; 2023 Dec; 42(12):3299-3309. PubMed ID: 37537315
[TBL] [Abstract][Full Text] [Related]
5. Vincristine-cyclophosphamide combination therapy positively affects T-cell subset distribution in systemic lupus erythematosus patients.
Chen J; Ding L; Meng W; Yang J; Yan C; Xie J; Jing L; Li X; Fu Z
Med Sci Monit; 2015 Feb; 21():505-10. PubMed ID: 25683262
[TBL] [Abstract][Full Text] [Related]
6. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
Feng X; Gu F; Chen W; Liu Y; Wei H; Liu L; Yin S; Da Z; Sun L
Chin Med J (Engl); 2014; 127(21):3718-23. PubMed ID: 25382325
[TBL] [Abstract][Full Text] [Related]
7. Decreased blood levels of B lymphocytes and NK cells in patients with systemic lupus erythematosus (SLE) infected with papillomavirus (HPV).
Abud-Mendoza C; Cuevas-Orta E; Santillán-Guerrero EN; Martínez-Martínez MU; Hernández-Castro B; Estrada-Capetillo L; González-Amaro R; Baranda L
Arch Dermatol Res; 2013 Mar; 305(2):117-23. PubMed ID: 22752509
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.
Karim MY; Alba P; Cuadrado MJ; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
Rheumatology (Oxford); 2002 Aug; 41(8):876-82. PubMed ID: 12154204
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
Kawazoe M; Kaneko K; Yamada Z; Masuoka S; Mizutani S; Yamada S; Shikano K; Sato H; Kaburaki M; Muraoka S; Kawai S; Nanki T
Clin Rheumatol; 2019 Jun; 38(6):1571-1578. PubMed ID: 30778862
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.
van Leuven SI; Mendez-Fernandez YV; Wilhelm AJ; Wade NS; Gabriel CL; Kastelein JJ; Stroes ES; Tak PP; Major AS
Ann Rheum Dis; 2012 Mar; 71(3):408-14. PubMed ID: 21953346
[TBL] [Abstract][Full Text] [Related]
11. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.
Feldman CH; Marty FM; Winkelmayer WC; Guan H; Franklin JM; Solomon DH; Costenbader KH; Kim SC
Arthritis Rheumatol; 2017 Feb; 69(2):387-397. PubMed ID: 27589220
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk.
Bijl M; Horst G; Bootsma H; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2003 Jun; 62(6):534-9. PubMed ID: 12759290
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.
Jonsson CA; Svensson L; Carlsten H
Clin Exp Immunol; 1999 Jun; 116(3):534-41. PubMed ID: 10361247
[TBL] [Abstract][Full Text] [Related]
14. Changes of frequency and expression level of CD161 in CD8
Park Y; Lim J; Kim SY; Kwon GC; Koo SH; Kim J
Microbiol Immunol; 2020 Jul; 64(7):532-539. PubMed ID: 32343447
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.
Hu W; Liu Z; Chen H; Tang Z; Wang Q; Shen K; Li L
Chin Med J (Engl); 2002 May; 115(5):705-9. PubMed ID: 12133539
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
[TBL] [Abstract][Full Text] [Related]
17. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
[TBL] [Abstract][Full Text] [Related]
18. Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naïve systemic lupus erythematosus.
Jin L; Weiqian C; Lihuan Y
Int J Rheum Dis; 2013 Dec; 16(6):698-708. PubMed ID: 24286662
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus.
Eickenberg S; Mickholz E; Jung E; Nofer JR; Pavenstadt HJ; Jacobi AM
Arthritis Res Ther; 2012; 14(3):R110. PubMed ID: 22571761
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipients.
Böhler T; Canivet C; Galvani S; Therville N; Salvayre R; Negre-Salvayre A; Durand D; Thomsen M; Rostaing L; Kamar N
Int Immunopharmacol; 2008 May; 8(5):769-73. PubMed ID: 18387521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
